AHA PREVENT 10-year ASCVD risk
1 paper4 findings
- Humans1
Effects
4Trail Making Test Part A completion time
upin humans1
1 study
Trail Making Test Part A completion time
upin humans1
AHA PREVENT 10-year ASCVD risk increases trail Making Test Part A completion time in humans (β = +2.85 s/year).
Humanswithout baseline CVDn = 383
The journal of prevention of Alzheimer's disease6 Aug 2026
Delayed memory
downin humans1
1 study
Delayed memory
downin humans1
AHA PREVENT 10-year ASCVD risk impairs delayed memory in humans (β = -1.36).
Humanswithout baseline CVDn = 383
The journal of prevention of Alzheimer's disease6 Aug 2026
Attention
downin humans1
1 study
Attention
downin humans1
AHA PREVENT 10-year ASCVD risk impairs attention in humans (β = -1.25).
Humanswithout baseline CVDn = 383
The journal of prevention of Alzheimer's disease6 Aug 2026
Cognitive function
downin humans1
1 study
Cognitive function
downin humans1
AHA PREVENT 10-year ASCVD risk impairs cognitive function in humans (β = -1.22 points/year per 10 % higher risk).
Humanswithout baseline CVDn = 383
The journal of prevention of Alzheimer's disease6 Aug 2026